Required Accuracy of MR-US Registration for Prostate Biopsies
暂无分享,去创建一个
Geert J. S. Litjens | Thomas Hambrock | Jelle O. Barentsz | Henkjan J. Huisman | Wendy J. M. van de Ven | H. Huisman | G. Litjens | J. Barentsz | T. Hambrock | W. J. M. Ven
[1] N M deSouza,et al. Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer. , 2008, Clinical radiology.
[2] Tsuyoshi Mitake,et al. Real‐time Virtual Sonography for navigation during targeted prostate biopsy using magnetic resonance imaging data , 2010, International journal of urology : official journal of the Japanese Urological Association.
[3] Thomas Hambrock,et al. Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging-guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohort. , 2012, European urology.
[4] Namkug Kim,et al. Apparent diffusion coefficient: Prostate cancer versus noncancerous tissue according to anatomical region , 2008, Journal of magnetic resonance imaging : JMRI.
[5] H. Hricak,et al. Prostate cancer imaging , 2008, Acta radiologica.
[6] Kazuro Sugimura,et al. Prostate cancer detection with 3 T MRI: Comparison of diffusion‐weighted imaging and dynamic contrast‐enhanced MRI in combination with T2‐weighted imaging , 2010, Journal of magnetic resonance imaging : JMRI.
[7] Jocelyne Troccaz,et al. MR prior based automatic segmentation of the prostate in TRUS images for MR/TRUS data fusion , 2010, 2010 IEEE International Symposium on Biomedical Imaging: From Nano to Macro.
[8] Thomas Hambrock,et al. Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen. , 2010, The Journal of urology.
[9] Peter Guion,et al. Initial clinical experience with real‐time transrectal ultrasonography‐magnetic resonance imaging fusion‐guided prostate biopsy , 2008, BJU international.
[10] Zeike A. Taylor,et al. MR to ultrasound registration for image-guided prostate interventions , 2012, Medical Image Anal..
[11] Katsuyuki Nakanishi,et al. Clinical utility of apparent diffusion coefficient (ADC) values in patients with prostate cancer: Can ADC values contribute to assess the aggressiveness of prostate cancer? , 2011, Journal of magnetic resonance imaging : JMRI.
[12] Thomas Hambrock,et al. Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. , 2011, Radiology.
[13] William J Catalona,et al. Serial biopsy results in prostate cancer screening study. , 2002, The Journal of urology.
[14] A. Jemal,et al. Global Cancer Statistics , 2011 .
[15] Katsuyoshi Ito,et al. Apparent diffusion coefficient values in peripheral and transition zones of the prostate: Comparison between normal and malignant prostatic tissues and correlation with histologic grade , 2008, Journal of magnetic resonance imaging : JMRI.
[16] H. Shinmoto,et al. Prostate cancer screening: The clinical value of diffusion‐weighted imaging and dynamic MR imaging in combination with T2‐weighted imaging , 2007, Journal of magnetic resonance imaging : JMRI.
[17] A. Fenster,et al. Assessment of image registration accuracy in three-dimensional transrectal ultrasound guided prostate biopsy. , 2010, Medical physics.
[18] S. Fosså,et al. Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population‐based study , 2009, BJU international.
[19] Sheng Xu,et al. Realtime TRUS/MRI Fusion Targeted-Biopsy for Prostate Cancer: A Clinical Demonstration of Increased Positive Biopsy Rates , 2010, Prostate Cancer Imaging.